Back to Journals » Therapeutics and Clinical Risk Management » Volume 18

An Evaluation of Cabozantinib for the Treatment of Renal Cell Carcinoma: Focus on Patient Selection and Perspectives

Total article views   HTML views PDF downloads Totals
10,587 Dovepress* 9,467+ 294 9,761
PubMed Central* 1,120 172 1,292
Totals 10,587 466 11,053
*Since 2 June 2022
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 1 1

View citations on PubMed and Google Scholar